Analysts’ Viewpoint
The global medical foods market experienced significant growth in the past few years, driven by increase in demand for specialized nutrition products that address specific medical conditions. Medical foods are specially formulated products that are intended for the dietary management of diseases and medical conditions that have unique nutritional requirements. Rise in prevalence of chronic diseases, such as diabetes, cancer, and Alzheimer's disease, is a major factor propelling market expansion. Increase in consumer interest in personalized nutrition is another factor bolstering market development.
Advances in technology and research on medical foods tailored to specific patient needs offer lucrative opportunities for market players. Manufacturers are focused on ensuring that medical foods are safe, effective, and accessible to patients.
Medical foods are specially formulated products that are intended for the dietary management of diseases and medical conditions that have unique nutritional requirements. Unlike conventional foods, medical foods are designed to be consumed under the supervision of a healthcare professional and are not typically available over the counter.
Medical foods are intended to provide targeted nutritional support to patients with specific medical needs. These could contain various ingredients, including vitamins, minerals, amino acids, and other nutrients, which are carefully selected to support the health and well-being of patients with specific medical conditions.
Some common examples of medical foods include products for the management of metabolic disorders, such as phenylketonuria (PKU), which requires a strict low-protein diet; and products for the management of neurological conditions, such as Alzheimer's disease, which may require increased intake of certain nutrients.
Medical foods are regulated by the U.S. Food and Drug Administration (FDA) and must meet certain criteria to be considered medical food. These criteria include being intended for the dietary management of a specific medical condition, used under medical supervision, and formulated to meet distinctive nutritional requirements.
Increase in awareness about the importance of nutrition in managing health and well-being is driving the global medical foods business growth. This trend is driven by a range of factors, including rise in rate of chronic diseases, aging global population, and increase in demand for personalized nutrition.
The incidence rate of chronic diseases, such as diabetes, obesity, and heart diseases, has increased in the past few years. These conditions can often be managed through diet and nutrition. This has led to increase in demand for medical foods that are designed to support the management of these conditions. For instance, Nestle's Glucerna products are designed for people with diabetes and are formulated to help manage blood sugar levels.
Aging global population is another factor propelling market progress. The nutritional needs of people could change with age, and there is increasing demand for medical foods that can support these needs of older adults. For instance, Abbott Laboratories offers Ensure products, which are designed to provide complete nutrition for older adults who may have difficulty consuming conventional foods.
Increase in awareness about the importance of nutrition is a key driver of the global medical foods industry. As consumers become more educated about the role of nutrition in maintaining good health, they are seeking out specialized products that could address specific health concerns and conditions.
Medical foods are typically prescribed by healthcare professionals and are formulated to meet unique nutritional requirements that cannot be met by conventional foods alone. Demand for these foods is expected to continue to rise as the importance of nutrition in managing chronic diseases and conditions becomes better understood.
The regulatory environment for medical foods is an important factor fueling market expansion. In the U.S., the Food and Drug Administration (FDA) provides clear guidelines for the development and marketing of these foods. A favorable regulatory environment for these foods has encouraged investment in the sector and led to the development of a range of innovative products that could help manage different medical conditions. Investment in the development of medical foods has surged in the past few years, as companies strive to capitalize on the growing demand for personalized nutrition solutions.
Integration with digital health technologies is bolstering global medical foods market growth. Digital health technologies are used to improve patient outcomes by providing personalized nutrition recommendations and tracking patient progress. Mobile apps and wearables are used to track patient progress. These tools could help patients monitor food intake, track progress toward nutritional goals, and provide personalized recommendations based on individual needs. For instance, the Nutrino app uses artificial intelligence to create personalized meal plans and track nutrition data in real-time.
Digital health platforms are also used to connect patients with healthcare providers and nutritionists. These platforms allow patients to receive personalized nutrition advice from experts, and provide a convenient way for patients to track their progress and receive feedback. For instance, MyPlate by Livestrong app connects users with a nutrition coach who can provide personalized nutrition advice and track progress toward health goals.
Digital health technologies are also being used to develop new medical food products that are tailored to individual patient needs. For instance, Nutricia's FODMAP range of medical foods is designed to help people with irritable bowel syndrome, and is based on the results of a clinical trial that used a digital platform to identify patients who could benefit from a low FODMAP diet.
In terms of product type, the powder segment dominated the global medical foods market in 2022 due to its ease of use and versatility. Powdered medical foods are a convenient way to provide complete nutrition to patients. These can be easily mixed with liquids or other foods to create different nutritional products.
One of the key advantages of powdered medical foods is convenience. Powdered products are easy to transport and store, and have a long shelf life. This makes them an ideal choice for patients who need to manage their nutrition over an extended period. These foods also offer high degree of flexibility in terms of dosing, as these could be easily adjusted to meet the individual needs of each patient.
Powdered medical foods are also versatile. These can be mixed with different liquids and foods to create customized nutritional products that meet the unique needs of each patient. For instance, these foods can be mixed with water or milk to create a drink, or these can be added to smoothies or other foods to boost their nutritional value.
Popularity of powdered medical foods is reflected in the growth of the segment. It is expected to dominate the global market in the next few years. The segment is likely to be driven by increase in demand for convenient and versatile nutritional products that can be tailored to individual patient needs.
Based on disease type, the gastrointestinal disorders segment is expected to grow at a faster pace than other segments. This is ascribed to rise in prevalence of gastrointestinal disorders, increase in awareness about the importance of gut health, and development of new medical foods specifically designed to support digestive health.
Rise in prevalence of conditions, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD), is another key factor propelling the gastrointestinal disorders segment. These conditions could often be managed through dietary changes and usage of medical foods that are formulated to support digestive health. Therefore, demand for these foods that are designed to meet the specific nutritional needs of patients with gastrointestinal disorders is increasing.
In terms of route of administration, the oral segment dominated the global medical foods market in 2022. The segment is projected to grow at a rapid pace during the forecast period. The segment includes medical foods that are designed to be taken orally, such as beverages, powders, and snacks. These products can be consumed by patients without the need for medical supervision, making them an ideal choice for patients who need to manage their nutrition at home or on-the-go.
Development of new products that are tailored to the specific nutritional needs of different patient populations is another factor driving the segment. For instance, oral medical foods that are designed to support the nutritional needs of patients with conditions such as diabetes, cancer, and malnutrition are now available in the market. These products provide a convenient way for patients to obtain the nutrients they need to support their health.
Based on distribution channel, the pharmacies & drug stores segment led the global medical foods market in 2022. The segment is expected to grow at a faster pace in the next few years. This segment includes medical foods that are sold through pharmacies and drug stores, either over-the-counter or with a prescription.
The pharmacies & drug stores segment is driven by increase in focus on preventive healthcare. As consumers become aware about the importance of nutrition in maintaining good health, they are seeking out medical foods that can help to prevent and manage health conditions. Pharmacies and drug stores are well-positioned to meet this demand, offering a range of medical foods that support different health needs.
As per medical foods industry trends, North America accounted for the largest share of the global medical foods market in 2022. Rise in prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disease, is driving demand for these foods in the region. Additionally, increase in awareness about the importance of nutrition in maintaining good health and well-established healthcare infrastructure are ascribed to North America's global dominance.
Europe is also a significant market for medical foods, driven by increase in consumer awareness about health and wellness. Aging population and rise in demand for products that could support specific health conditions are expected to propel the market in the region in the next few years. Additionally, regulatory frameworks in Europe are supportive of the development and marketing of these foods.
The market in Asia Pacific is expected to witness significant growth during the forecast period. Rise in disposable income, increase in health-consciousness, and large population with chronic diseases are driving demand for medical foods in the region. Additionally, a growing middle class is expected to increase demand for these products. However, regulatory hurdles and lack of awareness about the benefits of these foods in some parts of the region are likely to hamper market growth.
This report provides profiles of leading players operating in the global medical foods market. These include Nutricia (Danone), Nestlé S.A., Abbott Laboratories, Mead Johnson Nutrition, Fresenius Kabi, Friso, Morinaga Milk Industry, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc., and Medtrition, Inc. These players engage in merger & acquisition, strategic collaborations, and new product launches to expand presence and gain global medical foods market share.
The report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent advancements in the market.
|
Attribute |
Detail |
|
Size in 2022 |
US$ 23.0 Bn |
|
Forecast (Value) in 2031 |
More than US$ 44.0 Bn |
|
Growth Rate (CAGR) 2023-2031 |
7.5% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2022 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 23.0 Bn in 2022
It is projected to reach more than US$ 44.0 Bn by 2031
The CAGR is anticipated to be 7.5% from 2023 to 2031
The powder segment held the largest share in 2022
North America is expected to account for the significant share during the forecast period.
Nutricia (Danone), Nestlé S.A., Abbott Laboratories, Mead Johnson Nutrition, Fresenius Kabi, Friso, Morinaga Milk Industry, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Inc., and Medtrition, Inc. are the prominent players in the market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Foods Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Key Insights
5.1. Important market developments
5.2. Top 3 Players Operating in the Market Space
5.3. New competitive market entrants
5.4. Medical food regulation overview
5.5. Reimbursement Scenario
5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples
6. Global Medical Foods Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Pills
6.3.2. Powder
6.3.3. Liquid
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Foods Market Analysis and Forecast, by Disease Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017–2031
7.3.1. Orphan Disease
7.3.1.1. Duchenne Muscular Dystrophy (DMD)
7.3.1.2. Sickle Cell Anemia
7.3.1.3. Hemophilia
7.3.1.4. Others
7.3.2. Cancer
7.3.3. Neurological & Psychological Disorders
7.3.4. Metabolic Disorders
7.3.5. Pain Management
7.3.6. Gastrointestinal Disorders
7.3.7. Ophthalmology
7.3.8. Diabetes
7.3.9. Phenylketonuria (PKU)
7.3.10. Epilepsy
7.4. Market Attractiveness Analysis, by Disease Type
8. Global Medical Foods Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2017–2031
8.3.1. Oral
8.3.2. Enteral
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017–2031
9.3.1. Pharmacies & Drug Stores
9.3.2. Online Channels
9.3.3. Supermarkets & Hypermarkets
9.3.4. Others
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Medical Foods Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Medical Foods Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Pills
11.2.2. Powder
11.2.3. Liquid
11.2.4. Others
11.3. Market Value Forecast, by Disease Type, 2017–2031
11.3.1. Orphan Disease
11.3.1.1. Duchenne Muscular Dystrophy (DMD)
11.3.1.2. Sickle Cell Anemia
11.3.1.3. Hemophilia
11.3.1.4. Others
11.3.2. Cancer
11.3.3. Neurological & Psychological Disorders
11.3.4. Metabolic Disorders
11.3.5. Pain Management
11.3.6. Gastrointestinal Disorders
11.3.7. Ophthalmology
11.3.8. Diabetes
11.3.9. Phenylketonuria (PKU)
11.3.10. Epilepsy
11.4. Market Value Forecast, by Route of Administration, 2017–2031
11.4.1. Oral
11.4.2. Enteral
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Pharmacies & Drug Stores
11.5.2. Online Channels
11.5.3. Supermarkets & Hypermarkets
11.5.4. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Disease Type
11.7.3. By Route of Administration
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Medical Foods Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Pills
12.2.2. Powder
12.2.3. Liquid
12.2.4. Others
12.3. Market Value Forecast, by Disease Type, 2017–2031
12.3.1. Orphan Disease
12.3.1.1. Duchenne Muscular Dystrophy (DMD)
12.3.1.2. Sickle Cell Anemia
12.3.1.3. Hemophilia
12.3.1.4. Others
12.3.2. Cancer
12.3.3. Neurological & Psychological Disorders
12.3.4. Metabolic Disorders
12.3.5. Pain Management
12.3.6. Gastrointestinal Disorders
12.3.7. Ophthalmology
12.3.8. Diabetes
12.3.9. Phenylketonuria (PKU)
12.3.10. Epilepsy
12.4. Market Value Forecast, by Route of Administration, 2017–2031
12.4.1. Oral
12.4.2. Enteral
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Pharmacies & Drug Stores
12.5.2. Online Channels
12.5.3. Supermarkets & Hypermarkets
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. by Product Type
12.7.2. By Disease Type
12.7.3. By Route of Administration
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Medical Foods Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Pills
13.2.2. Powder
13.2.3. Liquid
13.2.4. Others
13.3. Market Value Forecast, by Disease Type, 2017–2031
13.3.1. Orphan Disease
13.3.1.1. Duchenne Muscular Dystrophy (DMD)
13.3.1.2. Sickle Cell Anemia
13.3.1.3. Hemophilia
13.3.1.4. Others
13.3.2. Cancer
13.3.3. Neurological & Psychological Disorders
13.3.4. Metabolic Disorders
13.3.5. Pain Management
13.3.6. Gastrointestinal Disorders
13.3.7. Ophthalmology
13.3.8. Diabetes
13.3.9. Phenylketonuria (PKU)
13.3.10. Epilepsy
13.4. Market Value Forecast, by Route of Administration, 2017–2031
13.4.1. Oral
13.4.2. Enteral
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Pharmacies & Drug Stores
13.5.2. Online Channels
13.5.3. Supermarkets & Hypermarkets
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. by Product Type
13.7.2. By Disease Type
13.7.3. By Route of Administration
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Medical Foods Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Pills
14.2.2. Powder
14.2.3. Liquid
14.2.4. Others
14.3. Market Value Forecast, by Disease Type, 2017–2031
14.3.1. Orphan Disease
14.3.1.1. Duchenne Muscular Dystrophy (DMD)
14.3.1.2. Sickle Cell Anemia
14.3.1.3. Hemophilia
14.3.1.4. Others
14.3.2. Cancer
14.3.3. Neurological & Psychological Disorders
14.3.4. Metabolic Disorders
14.3.5. Pain Management
14.3.6. Gastrointestinal Disorders
14.3.7. Ophthalmology
14.3.8. Diabetes
14.3.9. Phenylketonuria (PKU)
14.3.10. Epilepsy
14.4. Market Value Forecast, by Route of Administration, 2017–2031
14.4.1. Oral
14.4.2. Enteral
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Pharmacies & Drug Stores
14.5.2. Online Channels
14.5.3. Supermarkets & Hypermarkets
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. by Product Type
14.7.2. By Disease Type
14.7.3. By Route of Administration
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Medical Foods Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Pills
15.2.2. Powder
15.2.3. Liquid
15.2.4. Others
15.3. Market Value Forecast, by Disease Type, 2017–2031
15.3.1. Orphan Disease
15.3.1.1. Duchenne Muscular Dystrophy (DMD)
15.3.1.2. Sickle Cell Anemia
15.3.1.3. Hemophilia
15.3.1.4. Others
15.3.2. Cancer
15.3.3. Neurological & Psychological Disorders
15.3.4. Metabolic Disorders
15.3.5. Pain Management
15.3.6. Gastrointestinal Disorders
15.3.7. Ophthalmology
15.3.8. Diabetes
15.3.9. Phenylketonuria (PKU)
15.3.10. Epilepsy
15.4. Market Value Forecast, by Route of Administration, 2017–2031
15.4.1. Oral
15.4.2. Enteral
15.5. Market Value Forecast, by Distribution Channel, 2017–2031
15.5.1. Pharmacies & Drug Stores
15.5.2. Online Channels
15.5.3. Supermarkets & Hypermarkets
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. by Product Type
15.7.2. By Disease Type
15.7.3. By Route of Administration
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Competitive Business Strategies
16.3. Company Profiles
16.3.1. Nutricia (Danone)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Nestlé S.A.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Abbott Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Mead Johnson Nutrition
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Fresenius Kabi
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Friso
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Morinaga Milk Industry
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Primus Pharmaceuticals, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Targeted Medical Pharma, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Medtrition, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031
Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017–2031
Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031
Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031
Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031
Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031
Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031
Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031
Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031
Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031
Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017‒2031
Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017‒2031
Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2031
Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
List of Figures
Figure 01: Global Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 02: Global Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 03: Global Medical Foods Market Revenue (US$ Mn), by Pills, 2017–2031
Figure 04: Global Medical Foods Market Revenue (US$ Mn), by Powder, 2017–2031
Figure 05: Global Medical Foods Market Revenue (US$ Mn), by Liquid, 2017–2031
Figure 06: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017–2031
Figure 07: Global Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 08: Global Medical Foods Market Attractiveness Analysis, by Disease Type, 2023–2031
Figure 09: Global Medical Foods Market Revenue (US$ Mn), by Orphan Disease, 2017–2031
Figure 10: Global Medical Foods Market Revenue (US$ Mn), by Cancer, 2017–2031
Figure 11: Global Medical Foods Market Revenue (US$ Mn), by Neurological & Psychological Disorders, 2017–2031
Figure 12: Global Medical Foods Market Revenue (US$ Mn), by Metabolic Disorders, 2017–2031
Figure 13: Global Medical Foods Market Revenue (US$ Mn), by Pain Management, 2017–2031
Figure 14: Global Medical Foods Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2017–2031
Figure 15: Global Medical Foods Market Revenue (US$ Mn), by Ophthalmology, 2017–2031
Figure 16 Global Medical Foods Market Revenue (US$ Mn), by Diabetes, 2017–2031
Figure 17: Global Medical Foods Market Revenue (US$ Mn), by Phenylketonuria (PKU), 2017–2031
Figure 18: Global Medical Foods Market Revenue (US$ Mn), by Epilepsy, 2017–2031
Figure 19: Global Medical Foods Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 20: Global Medical Foods Market Attractiveness Analysis, by Route of Administration, 2023–2031
Figure 21: Global Medical Foods Market Revenue (US$ Mn), by Oral, 2017–2031
Figure 22: Global Medical Foods Market Revenue (US$ Mn), by Enteral, 2017–2031
Figure 23: Global Medical Foods Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 24: Global Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 25: Global Medical Foods Market Revenue (US$ Mn), by Pharmacies & Drug Stores, 2017–2031
Figure 26: Global Medical Foods Market Revenue (US$ Mn), by Online Channels, 2017–2031
Figure 27: Global Medical Foods Market Revenue (US$ Mn), by Supermarkets & Hypermarkets, 2017–2031
Figure 28: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017–2031
Figure 29: Global Medical Foods Market Value Share Analysis, by Country, 2022 and 2031
Figure 30: Global Medical Foods Market Attractiveness Analysis, by Country, 2023–2031
Figure 31: North America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 32: North America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 33: North America Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: North America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 35 North America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 36: North America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 37: North America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031
Figure 38: North America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 39: North America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 40: Europe Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 41: Europe Medical Foods Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Europe Medical Foods Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 43: Europe Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 44: Europe Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 45: Europe Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 46: Europe Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 47: Europe Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 48: Europe Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031
Figure 49: Europe Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 50: Europe Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 51: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 52: Asia Pacific Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 53: Asia Pacific Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 54: Asia Pacific Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 55: Asia Pacific Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 56: Asia Pacific Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 57: Asia Pacific Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031
Figure 58: Asia Pacific Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 59: Asia Pacific Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 60: Latin America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 61: Latin America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 62: Latin America Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 63: Latin America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 64: Latin America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 65: Latin America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 66: Latin America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031
Figure 67: Latin America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 68: Latin America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 69: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 70: Middle East and Africa Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 71: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 72: Middle East and Africa Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
Figure 73: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
Figure 74: Middle East and Africa Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 75: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022–2031
Figure 76: Middle East and Africa Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 77: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Medical Foods Market
